Jefferies Financial Group Inc. Merck & Co., Inc. Call Options Transaction History

Jefferies Financial Group Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $7.41 Million - $8.6 Million	66,700 New	66,700 $7.57 Million
Q1 2024 May 13, 2024	SELL	$113.24 - $131.95 $1.36 Million - $1.58 Million	-12,000 Reduced 11.24%	94,800 $12.5 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $8.19 Million - $8.92 Million	81,800 Added 327.2%	106,800 $11.6 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $2.57 Million - $2.86 Million	25,000 New	25,000 $2.57 Million

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.